Thermo Fisher Scientific, Quintiles Transnational, and Repligen all benefit from growing biopharma R&D spending.
News & Analysis: IMS HEALTH HOLDINGS COM USD0.01
Runaway drug spending is costing Americans billions of dollars every year.
Exiting the fourth-quarter earnings season, WellCare Health Group, Edwards Lifesciences Corp, and IMS Health are among healthcare's best performers.
The large IMS Health Holdings Inc IPO highlights the surging investor popularity of healt-hcare IT companies.